Defined MicroRNAs Induce Aspects of Maturation in Mouse and Human Embryonic-Stem-Cell-Derived Cardiomyocytes  by Lee, Desy S. et al.
ReportDefined MicroRNAs Induce Aspects of Maturation in
Mouse and Human Embryonic-Stem-Cell-Derived
CardiomyocytesGraphical AbstractHighlightsd Coculture of ESC-CMs with endothelial cells improves
features of ESC-CM maturation
d Transfection of four miRNAs phenocopies this effect in
mouse and human ESC-CMs
d This miRNA combination targets ErbB4Lee et al., 2015, Cell Reports 12, 1960–1967
September 29, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.08.042Authors
Desy S. Lee, Jyh-Hong Chen,
David J. Lundy, ..., Shu Chien,





Lee et al. report that coculture of
embryonic stem cell (ESC)-derived
cardiomyocytes with endothelial cells
enhances ESC-CM maturity and
upregulates several microRNAs. Delivery
of selected microRNAs phenocopies this





ReportDefined MicroRNAs Induce Aspects
of Maturation in Mouse and Human
Embryonic-Stem-Cell-Derived Cardiomyocytes
Desy S. Lee,1,2 Jyh-Hong Chen,3,* David J. Lundy,2 Chung-Hung Liu,2 Shiaw-Min Hwang,4 Lil Pabon,5 Ru-Chi Shieh,2
Chien-Chang Chen,2 Sheng-Nan Wu,6 Yu-Ting Yan,2 Sho-Tone Lee,2 Po-Min Chiang,1 Shu Chien,7 Charles E. Murry,5,8,9
and Patrick C.H. Hsieh1,2,8,10,*
1Institute of Clinical Medicine, National Cheng Kung University, Tainan 704, Taiwan
2Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan
3Department of Medicine, National Cheng Kung University, Tainan 704, Taiwan
4Bioresource Collection and Research Center, Food Industry Research and Development Institute, Hsinchu 300, Taiwan
5Department of Pathology, Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington,
Seattle, WA 98109, USA
6Department of Physiology, National Cheng Kung University, Tainan 704, Taiwan
7Department of Bioengineering, University of California at San Diego, San Diego, CA 92093, USA
8Department of Bioengineering, University of Washington, Seattle, WA 98109, USA
9Department of Medicine/Cardiology, University of Washington, Seattle, WA 98109, USA
10Division of Cardiovascular Surgery, National Taiwan University Hospital, Taipei 100, Taiwan
*Correspondence: phsieh@ibms.sinica.edu.tw (P.C.H.H.), jyhhong@mail.ncku.edu.tw (J.-H.C.)
http://dx.doi.org/10.1016/j.celrep.2015.08.042
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARY
Pluripotent-cell-derived cardiomyocytes have great
potential for use in research andmedicine, but limita-
tions in their maturity currently constrain their useful-
ness.Here,we report amethod for improving features
of maturation in murine and human embryonic-stem-
cell-derived cardiomyocytes (m/hESC-CMs). We
found that coculturingm/hESC-CMs with endothelial
cells improves their maturity and upregulates several
microRNAs. Delivering four of these microRNAs,
miR-125b-5p, miR-199a-5p, miR-221, and miR-222
(miR-combo), to m/hESC-CMs resulted in improved
sarcomere alignment and calcium handling, a more
negative resting membrane potential, and increased
expression of cardiomyocyte maturation markers.
Although this could not fully phenocopy all adult car-
diomyocyte characteristics, these effects persisted
for two months following delivery of miR-combo.
A luciferase assay demonstrated that all fourmiRNAs
target ErbB4, and siRNA knockdown of ErbB4
partially recapitulated the effects of miR-combo. In
summary, a combination of miRNAs induced via
endothelial coculture improved ESC-CM maturity, in
part through suppression of ErbB4 signaling.INTRODUCTION
Cells differentiated from embryonic stem cells (ESCs) and
induced pluripotent stem cells (iPSCs) could form ideal platforms1960 Cell Reports 12, 1960–1967, September 29, 2015 ª2015 The Afor in vitro disease modeling and the development and testing
of new therapeutics. These tools are of importance in fields in
which primary human cells and tissues are not readily available,
such as in cardiac or neurological research. However, one major
obstacle is that cells derived from ESCs/iPSCs are generally
immature and tend to display the structural and functional attri-
butes of fetal cells, rather than the adult phenotype (Blum
et al., 2012; Maroof et al., 2013; Yang et al., 2014a).
Cardiac disease is one of the severe causes of morbidity
and mortality in the world (Lloyd-Jones et al., 2010). To this
end, several groups have developed protocols for differentiating
pluripotent stem cells into cardiomyocytes (CMs). However,
these differentiated cells remain immature in both morphology
and performance. This is not surprising, given that neonatal hu-
man cardiomyocytes require many years of maturation in vivo
before fully adopting the adult phenotype, whereas ESC/iPSC-
CM are differentiated for only a matter of weeks (Peters et al.,
1994). An immature pluripotent-cell-derived cardiomyocyte ex-
hibits a round cell shape, a disorganized contractile apparatus,
a single nucleus, limited calcium-handling ability, and a resting
membrane potential of around –60 mV. In contrast, a mature
adult cardiomyocyte is significantly larger, is rod-shaped, has
highly organized sarcomeres, has polarized connexin-43 (Cx-
43), and has a more negative resting potential of around
–90 mV. A larger proportion of cells are also multinucleated
(Yang et al., 2014a). A fully mature cardiomyocyte also shows
regularly spaced transverse tubules (T tubules), which are essen-
tial for proper excitation-contraction coupling with even distribu-
tion of action potentials (Ziman et al., 2010).
Due to these structural and functional differences, cardiomyo-
cytes that have been differentiated from pluripotent stem cells
in vitro may be unreliable when used for disease modeling, drug
screening, or cell-based therapies (Kim et al., 2013; Laflammeuthors
Figure 1. Coculture with Endothelial Cells
Enhances Aspects of ESC-Derived Cardio-
myocyte Maturation and Upregulates Four
MicroRNAs
(A) Mouse embryonic-stem-cell-derived car-
diomyocytes (mESC-CMs) were cultured alone in
2% (left), 10% (right) FBS, or with endothelial cells
(+EC) or fibroblasts (+FB) for 1, 3, or 7 days. Scale
bar, 50 mm; green, a-MHC (EGFP).
(B) Immunofluorescence staining of mESC-CMs
cultured alone or with ECs at day 3. Red, a-sar-
comeric actinin (a-actinin); blue, DAPI. Scale
bar, 25 mm.
(C) Ultrastructural images showing sarcomere
structure of mESC-CMs after 3 days of coculture
with ECs (arrowhead, Z disk; arrow, I band). Scale
bar, 1 mm.
(D) Representative tracing of spontaneous Ca2+
transients of mESC-CMs cultured alone or with
ECs at day 3. The time constant of Ca2+ transient
decay, characterizing the speed of recovery, was
quantified in each group.
Means ± SEM are shown. For statistical data, at
least nR 3; ***p < 0.001.
See also Figure S1.andMurry, 2005; Navarrete et al., 2013; Yang et al., 2014a). Given
that previously undetected cardiac toxicity is one of the leading
causes of drug development failure, the problem appears to be
significant (Navarrete et al., 2013). Thus, the need for mature
ESC/iPSC-CMs is clearly recognized, and many groups have
attempted to improve ESC/iPSC-CM maturation by a variety of
methods (Kim et al., 2010; Kuppusamy et al., 2015; Nunes et al.,
2013; Yang et al., 2014b).
It is known that the function of cardiomyocytes is considerably
dependent on endothelial cells (Brutsaert, 2003; Hsieh et al.,
2006a) and that endothelial cells play a role in promoting cardio-
myocyte survival and organization (Hsieh et al., 2006b). In our
study, we found an increase of a group microRNAs (miRNAs)
when ESC-CMs were cocultured with endothelial cells. miRNAs,
a group of small noncoding RNAs that post-transcriptionally
repress the expression of their target genes in a sequence-
specific manner, have profound effects in orchestrating cardiac
development, function, and pathological responses to injury
(Cordes and Srivastava, 2009; Small et al., 2010). In this report,
we sought to determine whether miRNAs play a role in ESC-CM
maturation during coculture with endothelial cells.Cell Reports 12, 1960–1967, SepRESULTS
Coculture with Endothelial Cells
Induces Aspects of Maturation in
Mouse Embryonic-Stem-Cell-
Derived Cardiomyocytes
Mouse embryonic stem cells (mESCs)
stably transfected with a cardiac-spe-
cific alpha-MHC-driven EGFP reporter
(Takahashi et al., 2003) were differentiated
into cardiomyocytes (CMs) using the
hanging drop method; this yielded 15%
mESC-CMs (Figures S1A and S1B). These mESC-CMs were pu-
rified by fluorescence-activated cell sorting (FACS) and cocul-
tured with rat endothelial cells (ECs) (Figure S1C) or mouse car-
diac fibroblasts, which had been previously seeded on the plate.
We observed that mESC-CMs cocultured with ECs took on an
elongated cell shape and improved their alignment, compared
to when they were cultured alone or with fibroblasts (Figure 1A).
During development, rodent heart maturation is characterized
by a switch of fetal-specific myosin heavy-chain b-isoform
(b-MHC) to the a-isoform (a-MHC) that is predominantly ex-
pressed in adult rodent hearts (Lompre´ et al., 1984). ESC-CMs
were sorted from coculture by FACS, based on an EGFP+ signal,
and the a-/b-MHC ratio was assessed by quantitative real-time
PCR. We found a higher a-/b-MHC ratio in ESC-CMs that had
been cocultured with ECs, compared to ESC-CMs cultured
alone (Figure S1E), reflecting a change of ESC-CM maturity
following coculture.
Both immunofluorescence and ultrastructural analyses of
cocultured mESC-CMs revealed myofibrils with properly aligned
Z bands, whereas ESC-CMs cultured alone contained only
nascent myofibrils and poorly aligned, immature Z-bodiestember 29, 2015 ª2015 The Authors 1961
Figure 2. Defined MicroRNAs Promote
Several Maturation-Associated Changes in
mESC-CMs
(A) Heatmap showing the four most significantly
upregulated miRNAs upon coculture from three
independent experiments.
(B) Confirmation of upregulated miRNAs in mESC-
CMs using quantitative real-time PCR. EGFP+ cells
were sorted from the coculture system before
analysis.
(C) Immunofluorescence staining showing a-sar-
comeric actinin (a-actinin; red) and DAPI (blue) in
mouse ESC-CMs transfected with pre-Scr or miR-
combo after 3 days. Scale bar, 25 mm.
(D)Representative ultrastructural imagesofmESC-
CMs transfected with pre-Scr or miR-combo after
3 days showing sarcomere organization (arrow-
head, Z disk; arrow, I band). Scale bar, 1 mm.
(E) Representative ultrastructural images of mito-
chondria in mESC-CMs 3 days following trans-
fection with pre-Scr or miR-combo. Scale bar,
1 mm (top), 0.5 mm (bottom).
(F) A western blot shows Cx-43 in mESC-CMs
transfected with pre-Scr or miR-combo after
3 days. GAPDH was used as loading control.
(G) Representative tracing of spontaneous Ca2+
transients of mESC-CMs transfected with pre-
Scr or miR-combo after 3 days. The time con-
stant of Ca2+ transient decay, characterizing
the speed of recovery, was quantified in each
group.
Means ± SEM are shown. For statistical data, at
least nR 3; *p < 0.05, **p < 0.01, ***p < 0.001. See
also Figures S2 and S3.(Figures 1B and 1C). I bands, a marker of the mature phenotype,
could only be visualized in the EC coculture group (Figure 1C).
Calcium oscillations may also be used to characterize the matu-
rity of pluripotent-cell-derived cardiomyocytes. Therefore, we
measured calcium oscillations of cocultured ESC-CMs using
Fura-2, a Ca2+-sensitive dye. The rising slope and time to peak
were not significantly different between the two groups; how-
ever, a faster t decay indicates improved kinetics of Ca2+ clear-
ance from the cytosol of ESC-CMs cultured with ECs (Figure
1D). These data were supported by the elevation of the sarco-
plasmic reticulum Ca2+ ATPase, Serca2a in cocultured ESC-
CMs (Figure S1F).
Delivery of Four MicroRNAs Induces Several
Maturation-Associated Changes in Mouse ESC-CMs
In order to compare miRNA expression profiles between ECs
cocultured ESC-CMs and those cultured alone, we used FACS
to isolate ESC-CMs from coculture before extracting RNA
and performing an miRNA microarray (Figure S2A). We chose
candidates that were most differentially upregulated in EC-co-
cultured ESC-CMs in three independent experiments: these1962 Cell Reports 12, 1960–1967, September 29, 2015 ª2015 The Authorswere miR-125b-5p, miR-199a-5p, miR-
221, and miR-222 (Figure 2A). The
expression levels of these miRNAs were
then confirmed using quantitative real-
time PCR (Figures 2B and S2B). Interest-ingly, thesemiRNAs also showed elevation during the embryonic
stage of murine heart development (Figure S2C). All of these
miRNAs have been previously linked to cardiovascular disease
in different roles (Cardinali et al., 2009; Ge et al., 2011; Small
et al., 2010; van Rooij et al., 2006; Wong et al., 2012).
Next, we tested each of these miRNAs in gain-of-function as-
says using synthetic miRNA precursors (Figure S3A), using
the switch from b-MHC to a-MHC as a marker of maturation.
Transfecting individual miRNAs had no significant effect on the
a-/b-MHC ratio (Figure S3B). However, since it has been re-
ported that the combined overexpression of miRNAs is neces-
sary to exert their particular function (Hu et al., 2011; Miyoshi
et al., 2011), we reasoned that the addition of these four miRNAs
together (miR-combo) may be necessary to exert their effects.
As suspected, a significant enhancement of the a-/b-MHC ratio
was seen in ESC-CMs transfectedwithmiR-combo (Figure S3B),
reflecting a more mature phenotype. On the basis of these find-
ings, we used these four miRNAs in combination for further
experiments.
Next, we wanted to examine whether transfection with miR-
combo could replicate the changes in mESC-CM morphology
Figure 3. ErbB4 as a Common Target of
miR-Combo
(A) The expression of ErbB4 was characterized in
mESC-CMs using quantitative real-time PCR.
EGFP+ mESC-CMs were sorted from cocultures
before analysis.
(B) The expression of ErbB4 was examined in
mESC-CMs 48 hr following miR combo trans-
fection.
(C) A western blot shows the protein level of
ERBB4 in hESC-CMs after miR combo delivery.
GAPDH is shown as a loading control.
(D) The expression pattern of ErbB4 was deter-
mined in mouse heart at E10.5, E14.5, and E17.5
using quantitative real-time PCR.
(E) A luciferase reporter assay 48 hr post-trans-
fection shows that each miRNA targets the ErbB4
30 UTR.
(F) The a-to-bMHC ratio was examined in mESC-
CMs transfected with ErbB4 siRNA, relative to
siNeg (negative control) after 3 days. Data were
normalized to GAPDH.
(G) The Cx-43 gene level was determined in mES-
CMs transfected with ErbB4 siRNA, shown relative
to siNeg after 3 days. Data were normalized to
GAPDH.
(H) A western blot shows the protein level of Cx-43
in mESC-CMs transfected with siNeg, siErbB4-1,
or siErbB4-2 after 3 days.
(I) Immunofluorescence staining for a-sarcomeric
actinin (a-actinin; red) and DAPI (blue) in mESC-
CMs transfected with siNeg and siErbB4. Scale
bar, 25 mm.
Means ± SEM are shown. For statistical data, at
least nR 3; *p < 0.05, **p < 0.01. See also FigureS4.and calcium handling that we observed during coculture with
endothelial cells. Indeed, miR-combo-transfected mESC-CMs
showed a more elongated structure than scramble-transfected
controls (Figure S3C) and contained more aligned, mature myo-
fibrils in the cytoplasm (Figures 2C and S3D), similar to those
observed during EC coculture. miR-combo-transfected mESC-
CMs also showed more organized sarcomeric structures with
the presence of I bands (Figures 2D and S3E) and mitochondrial
inner membranes with more well-formed cristae (Figures 2E and
S3F). In addition, an increased protein level of the cardiomyocyte
gap junction component Cx-43 was also measured (Figure 2F).
An examination of calcium transients revealed a significant in-
crease in the decay rate of Ca2+ clearance, as evidenced by a
decrease in t decay time (Figure 2G). All of these findings point
to an improvement in the maturity status of mESC-CM following
miR-combo delivery.
ErbB4 is Downregulated following EC Coculture and
miR-Combo Delivery
miRNAs are known to post-transcriptionally repress the expres-
sion of target genes. Therefore, we carried out target prediction
analysis of miR-125b-5p, miR-199a-5p, miR-221, and miR-222
using TargetScan. TargetScan revealed that the 30 UTR of
ErbB4 is a common target of these four miRNAs (Figure S4A).
Indeed, we confirmed that there is a significant reduction in the
expression of ErbB4 in ESC-CMs following EC coculture andCell Repfollowing miR-combo delivery (Figures 3A–3C). ErbB4 expres-
sion was also found to decline during the prenatal stage of
cardiac development, inversely correlated with the expression
of these four miRNAs (Figure 3D). In order to verify that these
miRNAs can indeed target ErbB4, we cloned the ErbB4 30 UTR
sequence and ligated it behind the luciferase gene. We found
that each individual miRNA can significantly reduce luciferase
activity, suggesting that each miRNA in the miR-combo can
target ErbB4 (Figure 3E).
Since miR-combo treatment appears to target ErbB4 expres-
sion, we sought to examine whether the same maturation-
associated changes could be observed following knockdown
of ErbB4. Therefore, ESC-CMs were transfected with two
different ErbB4 small interfering RNA (siRNAs) (Figure S4B),
and we used the same assays to assess the maturity indices
of each group. We found a higher a-/b-MHC ratio (Figure 3F),
increased gene and protein expression of Cx-43 (Figures 3G
and 3H), and more aligned sarcomeres following ErbB4 knock-
down (siErbB4; Figure 3I). Notably, the degree of ESC-CM
maturity correlated with the knockdown efficiency of ErbB4
by the two different siRNAs, with the more efficient siRNA
achieving the more mature characteristics. Overall, these data
indicate that knockdown of ErbB4, as a target of miR-combo,
alters many aspects of ESC-CM morphology, gene expression,
and protein expression, in accordance with a more mature
phenotype.orts 12, 1960–1967, September 29, 2015 ª2015 The Authors 1963
Figure 4. Defined MicroRNAs Change
hESC-CM Characteristics in Accordance
with Enhanced Maturation
(A) Immunofluorescence staining for a-sarcomeric
actinin (a-actinin; red) and DAPI (blue) in human
ESC-CMs transfected with pre-Scr or miR-combo.
Scale bar, 25 mm.
(B) Quantification of average hESC-CM cell area
3 weeks post transfection with pre-Scr or miR-
combo.
(C) Quantification of binucleated hESC-CMs after
transfection with pre-Scr or miR-combo after
3 weeks.
(D) Representative recording of action potentials in
hESC-CMs 3weeks post-transfection with pre-Scr
or miR-combo.
(E) Quantification of recorded resting membrane
potentials (MDPs).
(F) Quantification of recorded action potential
amplitude (APA).
(G) The expression of ANFwas examined in hESC-
CMs overexpressed with pre-Scr or miR-combo.
(H) The protein level of Cx-43 was determined by
western blot in hESC-CMs. GAPDH was used as a
loading control.
(I) The expression of KIR2.1 was examined in
hESC-CMs 1month post-transfection with pre-Scr
or miR-combo.
(J) The protein level of KIR2.1 was determined by
western blot in hESC-CMs. GAPDH was used as a
loading control.
(K) Representative immunofluorescence staining
for a-sarcomeric actinin (a-actinin; red) and Cx-43
(green) in hESC-CMs transfected with pre-Scr or
miR-combo. Scale bar, 20 mm.
(L) Quantification of cell area of hESC-CMs after
transfection with pre-Scr or miR-combo after
2 months.
Means ± SEM are shown. For statistical data, at
least nR 3; **p < 0.01, ***p < 0.001.miR-Combo Promotes Several Maturation-Associated
Changes in Human ESC-CMs
Human adult cardiomyocytes are an essential tool for scientific
research, disease modeling, and drug discovery, yet obtaining
primary cells for research is exceedingly difficult. Since miR-
125b-5p, miR-199a-5p, miR-221, and miR-222 are all evolu-
tionarily conserved between mice and humans, we aimed to
examine whether our findings from murine ESCs could also
apply to the human system. Therefore, we induced cardiac dif-
ferentiation of H9 ESCs (Yang et al., 2014b) and carried out an
extensive characterization of hESC-CM maturity following miR-
combo delivery. In a similar manner to mESC-CMs, hESC-CMs
showed several morphological changes associated with
increased maturation. hESC-CMs transfected with miR-combo
showed more organized sarcomeres, a larger cell area, and a
higher binucleation ratio compared to scramble miRNA-trans-
fected controls, although they still retained a round cell shape
(Figures 4A–4C). These changes were also accompanied by a
more negative resting membrane potential and a larger ampli-1964 Cell Reports 12, 1960–1967, September 29, 2015 ª2015 The Atude of action potential, as measured by whole-cell patch clamp
(Figures 4D–4F), although still falling short of the electrophysio-
logical performance expected from adult human cardiomyo-
cytes. In addition, we examined the expression level of several
genes and proteins that are known to be differently expressed
in fetal and adult CMs. Our data show lower expression of ANF
and higher expression of Cx-43 and KIR2.1 following miR-
combo delivery (Figures 4G–4J). All of these factors indicate
that hESC-CM take on a more mature phenotype following
miR-combo delivery.
In order to form a useful platform for future research, ESC-CMs
would ideally show a long-term improvement in maturation,
rather than a transient effect. Therefore, we sought to investigate
the effects of miR-combo delivery after a longer culture period.
We followed hESC-CMs for 2 months after one single transfec-
tionwithmiR-comboand found that, after 2months, amore orga-
nized distribution of Cx-43 and enlarged cell size were still clearly
visible in miR-combo-treated hESC-CMs, compared to controls
thatwere cultured for the sameperiodof time (Figures 4Kand4L).uthors
DISCUSSION
Our findings provide a simple and rapid method for enhancing
the maturity of murine and human pluripotent-cell-derived
CMs in vitro. Although we could not fully recapitulate the adult
phenotype (i.e., rod-shaped cells with a resting potential
–90mV, peak action potential of 300mV, and T tubules), delivery
of miR-combo yields a population of cells that display many
more aspects of maturation than cells cultured under standard
conditions. This method has a number of advantages. First, it
is based on real physiological mechanisms, with clues taken
from the interactions occurring between cardiac endothelial cells
and cardiomyocytes. Second, miRNAs have the potential to
regulate many targets and complex pathways to derive their
effects, yet they are still more selective than small molecules.
Third, miRNAs are easily manipulated ex vivo and so are ideal
for increasing in vitro maturation of ESC-CMs. Finally, these
effects were demonstrated to persist for at least 2 months after
a single miR-combo delivery.
Given the heterogeneity of ECs, we sought to determine
whether different ESC-CMmaturation effects could be triggered
by different sources of ECs upon coculture. Surprisingly, we
found that, regardless of origin (heart, fat, or aorta) or even spe-
cies (mouse, rat, pig, or human), ECs could enhance the maturity
of ESC-CMs using the coculture system. In addition, this effect
could not be replicated by coculture with fibroblasts (Figures
S1D and S1E). Therefore, we postulate that it is a common prop-
erty of the various ECs that contributes to thematuration effect of
ESC-CMs.
We sought to shed light on how coculture with ECs increases
the level of miRNAs in ESC-CMs under a variety of conditions.
ESC-CMs were cultured in EC-conditioned medium, with a
lysate of freeze-thawed ECs, or on an extracellular matrix that
had been laid down by ECs. Interestingly, we found that only
the lysate of endothelial cells was able to significantly enhance
expression of these four miRNAs (Figure S2D). ESC-CMs
cultured with EC-conditioned medium or on matrix alone
showed only an immature phenotype, whereas ESC-CMs
cultured with EC lysate showed much more organized sarco-
meric structures (Figure S2E). This would indicate that the
main maturation-enhancing effect is not derived through a
secreted factor or via any matrix-driven effect. It is known that
miRNAs can be transferred directly between cells through gap
junctions (Katakowski et al., 2010), and we speculate that this
may be the mechanism by which EC coculture affects ESC-
CM miRNA concentrations. The precise nature of this interplay
requires further investigation, which we aim to carry out in the
future.
In terms of the mechanism underlying miR-combo-driven
maturation, we found that all four of these miRNAs can indepen-
dently repress ErbB4 and that expression of these four miRNAs
increases during cardiac development (Figures S2C and S3D).
This correlates with a previous report showing that ErbB4
expression is downregulated during heart development (Zhao
et al., 1999). In order to provide insight into the impact of
ErbB4 knockdown, we carried out microarray analysis following
siErbB4-2 delivery to ESC-CMs. Gene ontology analysis re-
vealed that genes related to the regulation of transcription, cellCell Repdifferentiation, organelle organization, and ion binding were
upregulated. We then chose several potentially relevant genes
(Tuba3a, Nefl, S100 g, and Cyp26a1) and confirmed their upre-
gulation by quantitative real-time PCR (Figures S4C and S4D).
We believe that further analysis of these targets, and others
determined during microarray analysis, should be investigated
for future studies into the mechanisms underlying ESC-CM
maturation.
Previous studies have shown that ErbB4 overexpression can
induce postnatal cardiomyocytes to proliferate and re-enter
the cell cycle, whereas ErbB4 inactivation suppresses it (Bersell
et al., 2009). In addition, an inverse relationship between cardio-
myocyte proliferation and maturation has been shown pre-
viously (Yang et al., 2014b; Zhang et al., 2010). To this end, we
believe that further study using pharmacological inhibition of
ErbB4, or indeed inhibition of cell proliferation, and examining
the effect on cardiomyocyte maturation would be of interest for
future investigation. However, since it is known that miRNAs
govern many functional pathways by targeting multiple genes,
we do not rule out the possibility that these miRNAs might
affect targets other than ErbB4 in mediating the maturation of
ESC-CMs.
In summary, we believe that our study has generated a valu-
able way to enhance the maturation of ESC-CMs in vitro.
Although no existing technique, including ours, is able to fully
imitate the adult cardiomyocyte phenotype, we hope that this
technique can improve the usefulness of pluripotent-stem-cell-
derived cardiomyocytes in a variety of applications and that a
similar approach will prove useful in other ESC/iPSC-derived
cells.
EXPERIMENTAL PROCEDURES
Routine Culture and Cardiac Differentiation of Mouse ESCs
A cardiac-specific a-MHC-driven EGFP reporter was stably transfected in
mESCs using a retroviral vector (Takahashi et al., 2003). Cardiac differentiation
was induced using the hanging drop technique with ascorbic acid (Sigma,
100 mmol/l). On days 7–10, EGFP-positive ESC-CMs were isolated and sorted
by FACS (BD FACSAria). For routine culture, rat arterial endothelial cells were
cultured in M199 with 15% fetal bovine serum (FBS). For routine culture,
mouse neonatal cardiac fibroblasts were cultured in DMEM-HG with 10%
FBS. During coculture experiments, ECs/FBs were cultured with ESC-CMs
in DMEM-LG with 2% FBS. ESC-CMs were cultured 1:1 with ECs or cardiac
fibroblasts pre-plated 1 day earlier (Hsieh et al., 2006b).
Exiqon miRNA Microarray
For each array, 1 mg of total RNA was labeled with Hy3 or Hy5 using the
miRCURY LNA microRNA Array Labeling Kit (Exiqon). Fluorescently labeled
RNA was hybridized to Exiqon miRCURY LNA miRNA arrays (v.11.0) (human,
mouse, and rat) (Exiqon) for 16 hr at 56C using a MAUI DNA microarray hy-
bridization station and SL mixer (BioMicro Systems). Arrays were washed
and scanned on an Axon GenePix 4000B scanner (Molecular Devices), and
GenePix results (GPR) files containing fluorescence intensities were generated
using GenePix Pro (v.6.0) (Molecular Devices) software. GPR files were loaded
into GeneSpring (v.11.5) (Agilent Technologies) and normalized using the
global Lowess algorithm. Flagged spots were removed from subsequent anal-
ysis. These microarray data are deposited at GEO: GSE69927.
Transient Transfection
ESC-CMs at 60%–70% confluence were transfected with pre-miR-125b,
pre-miR-199a, pre-miR-221, pre-miR-222 (PM10148, PM10893, PM10337,
and PM11376, respectively), or a negative control (scramble; 25 nM) usingorts 12, 1960–1967, September 29, 2015 ª2015 The Authors 1965
Pepmute as a transfection agent. For ErbB4 inhibition, siErbB4-1 and
siErbB4-2 (s201303, ss201304; Ambion) were compared to a negative control
using the same transfection agent (25 nM).
Cardiac Differentiation and Culture of Human ESCs
Protocols were approved by the Academia Sinica Institutional Review Board.
H9 cells were routinely maintained and expanded in feeder-free conditions
onMatrigel-coatedplates usingmouse-embryonic-fibroblast-conditionedme-
dium with 5 ng/ml bFGF. Prior to cardiac differentiation, cells were plated at a
density of 150,000 cells/cm2. To induce cardiac differentiation, media was re-
placed with RPMI-B27-insulin and 100 ng/ml recombinant human Activin A.
After 24 hr, medium was changed to RPMI-B27-insulin with BMP-4 and Wnt
agonist CHIR99021. 2 days later, the medium was switched to Wnt antagonist
Xav 939 (Yang et al., 2014b). Initial beating was typically observed approxi-
mately 10days post-induction. Only cell preparations containing>80%cardiac
troponin T-positive cardiomyocytes were used for further experiments.
Data Analysis
Data are expressed asmean±SEM. Statistical significancewas determined us-
ing a two-tailed Student’s t test or ANOVA, as appropriate. Differences between
groups were considered statistically significant at p values of less than 0.05.
ACCESSION NUMBERS
The accession numbers for the miRNA and ErbB4 siRNA microarray data re-
ported in this paper are GEO: GSE69927 and GEO: GSE69897.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.08.042.
AUTHOR CONTRIBUTIONS
Conceptualization, D.S.L., J.-H.C., and P.C.H.H.; Methodology, D.S.L., R.-
C.S., C.-C.C., C.E.M., and P.C.H.H.; Investigation, D.S.L. and C.H.L.; Writing
– Original Draft, D.S.L., D.J.L., and P.C.H.H.; Writing – Review & Editing,
D.S.L., D.J.L., L.P., S.C., C.E.M., and P.C.H.H.; Resources, R.C.S., C.-C.C.,
S.-N.W., and C.E.M.; Supervision, S.-M.H., Y.-T.Y, S.-T.L., P.-M.C., S.C.,
C.E.M., J.-H.C. and P.C.H.H.; Funding Acquisition, J.H.C. and P.C.H.H.
ACKNOWLEDGMENTS
This work was supported by the National Research Program for Bio-
pharmaceuticals of the Ministry of Science and Technology (MOST; 102-
2321-B-001-069, 104-2325-B-001-010, and 102-2314-B-039-032) and the
Academia Sinica Translational Medicine Program. The ExiqonmiRNAmicroar-
ray assays were performed by the DNA Microarray Core Laboratory at the
Institute of Plant and Microbial Biology, Academia Sinica, Taiwan. The authors
thank Mr. James Fugate for providing expert training in human cardiac differ-
entiation methods.
Received: March 1, 2015
Revised: June 22, 2015
Accepted: August 12, 2015
Published: September 10, 2015
REFERENCES
Bersell, K., Arab, S., Haring, B., and Ku¨hn, B. (2009). Neuregulin1/ErbB4
signaling induces cardiomyocyte proliferation and repair of heart injury. Cell
138, 257–270.
Blum, B., Hrvatin, S.S., Schuetz, C., Bonal, C., Rezania, A., and Melton, D.A.
(2012). Functional beta-cell maturation is marked by an increased glucose
threshold and by expression of urocortin 3. Nat. Biotechnol. 30, 261–264.1966 Cell Reports 12, 1960–1967, September 29, 2015 ª2015 The ABrutsaert, D.L. (2003). Cardiac endothelial-myocardial signaling: its role in car-
diac growth, contractile performance, and rhythmicity. Physiol. Rev. 83,
59–115.
Cardinali, B., Castellani, L., Fasanaro, P., Basso, A., Alema`, S., Martelli, F., and
Falcone, G. (2009). Microrna-221 and microrna-222 modulate differentiation
and maturation of skeletal muscle cells. PLoS ONE 4, e7607.
Cordes, K.R., and Srivastava, D. (2009). MicroRNA regulation of cardiovascu-
lar development. Circ. Res. 104, 724–732.
Ge, Y., Sun, Y., and Chen, J. (2011). IGF-II is regulated by microRNA-125b in
skeletal myogenesis. J. Cell Biol. 192, 69–81.
Hsieh, P.C.H., Davis, M.E., Lisowski, L.K., and Lee, R.T. (2006a). Endothelial-
cardiomyocyte interactions in cardiac development and repair. Annu. Rev.
Physiol. 68, 51–66.
Hsieh, P.C.H., MacGillivray, C., Gannon, J., Cruz, F.U., and Lee, R.T. (2006b).
Local controlled intramyocardial delivery of platelet-derived growth factor
improves postinfarction ventricular function without pulmonary toxicity. Circu-
lation 114, 637–644.
Hu, S., Huang, M., Nguyen, P.K., Gong, Y., Li, Z., Jia, F., Lan, F., Liu, J., Nag,
D., Robbins, R.C., and Wu, J.C. (2011). Novel microRNA prosurvival cocktail
for improving engraftment and function of cardiac progenitor cell transplanta-
tion. Circulation 124 (Suppl 11), S27–S34.
Katakowski, M., Buller, B., Wang, X., Rogers, T., and Chopp, M. (2010). Func-
tional microRNA is transferred between glioma cells. Cancer Res. 70, 8259–
8263.
Kim, C., Majdi, M., Xia, P., Wei, K.A., Talantova, M., Spiering, S., Nelson, B.,
Mercola, M., and Chen, H.S. (2010). Non-cardiomyocytes influence the
electrophysiological maturation of human embryonic stem cell-derived cardi-
omyocytes during differentiation. Stem Cells Dev. 19, 783–795.
Kim, C., Wong, J., Wen, J., Wang, S., Wang, C., Spiering, S., Kan, N.G.,
Forcales, S., Puri, P.L., Leone, T.C., et al. (2013). Studying arrhythmogenic
right ventricular dysplasia with patient-specific iPSCs. Nature 494, 105–110.
Kuppusamy, K.T., Jones, D.C., Sperber, H., Madan, A., Fischer, K.A., Rodri-
guez, M.L., Pabon, L., Zhu, W.-Z., Tulloch, N.L., Yang, X., et al. (2015). Let-7
family of microRNA is required for maturation and adult-like metabolism in
stem cell-derived cardiomyocytes. Proc. Natl. Acad. Sci. USA 112, E2785–
E2794.
Laflamme, M.A., and Murry, C.E. (2005). Regenerating the heart. Nat. Bio-
technol. 23, 845–856.
Lloyd-Jones, D., Adams, R.J., Brown, T.M., Carnethon, M., Dai, S., De Si-
mone, G., Ferguson, T.B., Ford, E., Furie, K., Gillespie, C., et al.; American
Heart Association Statistics Committee and Stroke Statistics Subcommittee
(2010). Executive summary: heart disease and stroke statistics–2010 update:
a report from the American Heart Association. Circulation 121, 948–954.
Lompre´, A.M., Nadal-Ginard, B., and Mahdavi, V. (1984). Expression of the
cardiac ventricular alpha- and beta-myosin heavy chain genes is developmen-
tally and hormonally regulated. J. Biol. Chem. 259, 6437–6446.
Maroof, A.M., Keros, S., Tyson, J.A., Ying, S.W., Ganat, Y.M., Merkle, F.T., Liu,
B., Goulburn, A., Stanley, E.G., Elefanty, A.G., et al. (2013). Directed differen-
tiation and functional maturation of cortical interneurons from human embry-
onic stem cells. Cell Stem Cell 12, 559–572.
Miyoshi, N., Ishii, H., Nagano, H., Haraguchi, N., Dewi, D.L., Kano, Y., Nishi-
kawa, S., Tanemura, M., Mimori, K., Tanaka, F., et al. (2011). Reprogramming
of mouse and human cells to pluripotency using mature microRNAs. Cell Stem
Cell 8, 633–638.
Navarrete, E.G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T.,
Sharma, A., Burridge, P.W., Patlolla, B., Lee, A.S., et al. (2013). Screening
drug-induced arrhythmia [corrected] using human induced pluripotent stem
cell-derived cardiomyocytes and low-impedance microelectrode arrays.
Circulation 128 (11 Suppl 1), S3–S13.
Nunes, S.S., Miklas, J.W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang,
J., Masse´, S., Gagliardi, M., Hsieh, A., et al. (2013). Biowire: a platform for
maturation of human pluripotent stem cell-derived cardiomyocytes. Nat.
Methods 10, 781–787.uthors
Peters, N.S., Severs, N.J., Rothery, S.M., Lincoln, C., Yacoub, M.H., and
Green, C.R. (1994). Spatiotemporal relation between gap junctions and fascia
adherens junctions during postnatal development of human ventricular
myocardium. Circulation 90, 713–725.
Small, E.M., Frost, R.J.A., and Olson, E.N. (2010). MicroRNAs add a new
dimension to cardiovascular disease. Circulation 121, 1022–1032.
Takahashi, T., Lord, B., Schulze, P.C., Fryer, R.M., Sarang, S.S., Gullans, S.R.,
and Lee, R.T. (2003). Ascorbic acid enhances differentiation of embryonic
stem cells into cardiac myocytes. Circulation 107, 1912–1916.
van Rooij, E., Sutherland, L.B., Liu, N., Williams, A.H., McAnally, J., Gerard,
R.D., Richardson, J.A., and Olson, E.N. (2006). A signature pattern of stress-
responsive microRNAs that can evoke cardiac hypertrophy and heart failure.
Proc. Natl. Acad. Sci. USA 103, 18255–18260.
Wong, S.S.Y., Ritner, C., Ramachandran, S., Aurigui, J., Pitt, C., Chandra, P.,
Ling, V.B., Yabut, O., and Bernstein, H.S. (2012). miR-125b promotes early
germ layer specification through Lin28/let-7d and preferential differentiation
of mesoderm in human embryonic stem cells. PLoS ONE 7, e36121.Cell RepYang, X., Pabon, L., and Murry, C.E. (2014a). Engineering adolescence: matu-
ration of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114,
511–523.
Yang, X., Rodriguez, M., Pabon, L., Fischer, K.A., Reinecke, H., Regnier, M.,
Sniadecki, N.J., Ruohola-Baker, H., and Murry, C.E. (2014b). Tri-iodo-l-thyro-
nine promotes thematuration of human cardiomyocytes-derived from induced
pluripotent stem cells. J. Mol. Cell. Cardiol. 72, 296–304.
Zhang, Y., Li, S., Yuan, L., Tian, Y., Weidenfeld, J., Yang, J., Liu, F., Chokas,
A.L., andMorrisey, E.E. (2010). Foxp1 coordinates cardiomyocyte proliferation
through both cell-autonomous and nonautonomousmechanisms. Genes Dev.
24, 1746–1757.
Zhao, Y.-Y., Feron, O., Dessy, C., Han, X., Marchionni, M.A., and Kelly, R.A.
(1999). Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveo-
lar microdomains in cardiac myocytes. Circ. Res. 84, 1380–1387.
Ziman, A.P., Go´mez-Viquez, N.L., Bloch, R.J., and Lederer, W.J. (2010). Exci-
tation-contraction coupling changes during postnatal cardiac development.
J. Mol. Cell. Cardiol. 48, 379–386.orts 12, 1960–1967, September 29, 2015 ª2015 The Authors 1967
